610 Safety and Efficacy of Lenabasum in Refractory Skin-Predominant Dermatomyositis Subjects Treated on an Open-Label Extension of Trial JBT101-DM-001

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.686

Related search